Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$16.36 - $21.39 $1.13 Million - $1.47 Million
-68,797 Closed
0 $0
Q2 2019

Aug 16, 2019

BUY
$16.93 - $26.22 $9,142 - $14,158
540 Added 0.79%
68,797 $1.28 Million
Q1 2019

May 13, 2019

BUY
$23.15 - $28.34 $162,050 - $198,380
7,000 Added 11.43%
68,257 $1.67 Million
Q4 2018

Feb 13, 2019

SELL
$22.03 - $32.01 $83,603 - $121,477
-3,795 Reduced 5.83%
61,257 $1.59 Million
Q3 2018

Nov 13, 2018

BUY
$30.0 - $40.85 $4,590 - $6,250
153 Added 0.24%
65,052 $2.06 Million
Q2 2018

Aug 10, 2018

BUY
$26.4 - $42.0 $1.71 Million - $2.73 Million
64,899 New
64,899 $2.52 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.